Clinician-Perceived Barriers and Facilitators for Initiation and Management of Noninvasive Ventilation Among Patients With Chronic Hypercapnia From COPD: A Qualitative Study.

Authors

Patricia J Checinski, Kaitland M Byrd, Wassim W Labaki, Thomas S Valley, Philip J Choi, Elizabeth M Viglianti

Published in

Chronic obstructive pulmonary diseases (Miami, Fla.). Sep 30, 2026. Epub Sep 30, 2026.

Abstract

Long-term non-invasive ventilation (NIV) improves survival and re-admission risk for patients with chronic hypercapnia from chronic obstructive pulmonary disease (COPD). However, outpatient NIV prescription remains low.
We conducted a qualitative study using semi-structured interviews with pulmonary physicians. We identified a convenience sample of community-affiliated outpatient pulmonologists who were recruited via email. Deductive and inductive thematic content analysis were used to identify how physicians screen and manage patients with COPD at risk for chronic hypercapnia and what barriers hinder their ability to care for this population.
Among 15 physicians interviewed, 13 were general pulmonologists. Two were sleep certified. They spent 52.5 + 21.3% of clinical time on average in outpatient care. While physicians identified FEV1 and serum bicarbonate (HCO3-) as parameters that would prompt a hypercapnia evaluation, there was no consistent threshold identified. Physicians initiated NIV themselves but varied in initial device selection and settings. Arterial blood gas (ABG) testing was infrequently used to monitor improvement and opinions differed on why and how initial NIV settings needed to be changed. Barriers to management included patient factors (e.g. NIV disinterest), physician discomfort (e.g. NIV troubleshooting), poor access to testing, lack of clinical support, and insurance and durable medical equipment (DME) company logistics.
Pulmonary physicians face multiple barriers in caring for this population, leading to variation in screening and management practices for chronic hypercapnia in COPD. Areas for improvement include standardized screening guidance, better clinical support and testing access, improved clinical education, and a streamlined approach to insurance approval.

PMID:
42852899
Bibliographic data and abstract were imported from PubMed on 09 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.